Closing soonCancer & oncology
Closes in 24 daysDept. of Defense — CDMRP · HT942526LCRPTRA
Summary: The fiscal year 2026 (FY26) Lung Cancer Research Program (LCRP) Translational Research Award (TRA) supports advanced translational research that will foster transformation of promising ideas in lung cancer into clinical applications. Research must address at least one…
Basic mechanisms & biologyTherapeutics & drug discoveryClinical trials
$9.1M totalDue Sep 2, 2026
Closing soonCancer & oncology
Closes in 24 daysDept. of Defense — CDMRP · HT942526PCRPDSA
Summary: The fiscal year 2026 (FY26) Prostate Cancer Research Program (PCRP) Data Science Award (DSA) supports research that develops or uses quantitative and analytical approaches, processes and/or systems to obtain knowledge and insight from large and/or complex sets of…
Basic mechanisms & biologyBiomarkers & diagnosticsData & infrastructure
$5.6M totalDue Sep 2, 2026
Closing soonCancer & oncology
Closes in 24 daysDept. of Defense — CDMRP · HT942526PCRPEIRA
Summary: The fiscal year 2026 (FY26) Prostate Cancer Research Program (PCRP) Early Investigator Research Award (EIRA) supports prostate cancer research conducted by investigators in the early stages of their careers with guidance from an experienced mentor. All applications must…
Training & career development
$8.8M totalDue Sep 2, 2026
Closing soonCancer & oncology
Closes in 24 daysDept. of Defense — CDMRP · HT942526PCRPIDA
Summary: The fiscal year 2026 (FY26) Prostate Cancer Research Program (PCRP) Idea Development Award (IDA) supports new ideas that represent innovative approaches to prostate cancer research and have the potential to make an important contribution to the PCRP mission. All…
$13.6M totalDue Sep 2, 2026
Closing soonCancer & oncology
Closes in 24 daysDept. of Defense — CDMRP · HT942526PCRPPRA
Summary: The fiscal year 2026 (FY26) Prostate Cancer Research Program (PCRP) Physician Research Award (PRA) Supports a mentored research experience to prepare physicians with clinical duties for careers in prostate cancer research. All applications must address one of the FY26…
Training & career development
$8.8M totalDue Sep 2, 2026
Closing soonHealthR01Clinical trial: Optional / allowed
Closes in 25 daysNIH Common Fund (NIH-CF) · RFA-RM-27-003
The NIH Director"s Transformative Research Award supports individual scientists or groups of scientists proposing bold, groundbreaking, exceptionally innovative, original, and/or unconventional research with the potential to create new scientific paradigms, establish entirely…
$8M totalDue Sep 3, 2026≈16% funded · FY24
Closing soonScience & R&D
Closes in 26 daysGeological Survey · G26AS00155
The U.S. Geological Survey (USGS) is offering a funding opportunity to a CESU partner for wildlife disease molecular diagnostic testing and capacity building. The USGS National Wildlife Health Center (NWHC) plays a critical role in identifying causes of morbidity and mortality…
Basic mechanisms & biologyBiomarkers & diagnosticsHealth disparities
$1 – $276KDue Sep 4, 2026
Closing soonHealth
Closes in 28 daysOffice of National Drug Control Policy · RD-AL-RDAAL-26-001
This project will establish applied drug policy research experiences for graduate students and recent post-graduates to conduct rigorous research studies and data analyses to support the National Drug Control Strategy. This research will investigate dynamic shifts in, and…
Therapeutics & drug discovery
$1 – $100KDue Sep 6, 2026
Closing soonSubstance use & addictionR01Clinical trial: Optional / allowed
Closes in 29 daysNational Institutes of Health (NIH) · PA-25-245
The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R01 Clinical Trial Optional mechanism focusing on alcohol health services. This NOFO will broadly focus on closing the treatment gap for individuals with alcohol use disorder (AUD); within this…
Basic mechanisms & biologyTherapeutics & drug discoveryHealth disparities
Up to $500KDue Sep 7, 2026≈16% funded · FY24
Closing soonSubstance use & addictionR34Clinical trial: Optional / allowed
Closes in 29 daysNational Institutes of Health (NIH) · PAR-25-192
The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R34 Clinical Trial Optional mechanism focusing on alcohol health services. This NOFO will broadly focus on closing the treatment gap for individuals with alcohol use disorder (AUD); within this…
Basic mechanisms & biologyTherapeutics & drug discoveryHealth disparities
Amount not listedDue Sep 7, 2026
Closing soonSubstance use & addictionR01Clinical trial: Required
Closes in 29 daysNational Institutes of Health (NIH) · PA-25-163
The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R01 Clinical Trial Required mechanism focusing on alcohol treatment and recovery research. This NOFO will focus broadly on topics relevant for treatment of and recovery from alcohol use disorder…
Basic mechanisms & biologyTherapeutics & drug discovery
Up to $500KDue Sep 7, 2026≈16% funded · FY24
Closing soonSubstance use & addictionR34Clinical trial: Required
Closes in 29 daysNational Institutes of Health (NIH) · PAR-25-193
The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R34 Clinical Trial Optional mechanism focusing on alcohol health services. This NOFO will broadly focus on closing the treatment gap for individuals with alcohol use disorder (AUD); within this…
Basic mechanisms & biologyTherapeutics & drug discoveryHealth disparities
Amount not listedDue Sep 7, 2026
Closing soonCancer & oncologyR01Clinical trial: Not allowed
Closes in 29 daysNational Institutes of Health (NIH) · PAR-25-153
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits applications for identification of small molecules that function to elucidate the biology of disease as chemical probes or function as agonists or antagonists of disease target(s) for…
Basic mechanisms & biologyBiomarkers & diagnosticsTherapeutics & drug discovery
Amount not listedDue Sep 7, 2026≈16% funded · FY24
Closing soonHealthR01Clinical trial: Not allowed
Closes in 29 daysNational Institutes of Health (NIH) · PAR-25-038
This Notice of Funding Opportunity (NOFO) encourages research on the biology of high-confidence risk factors associated with complex brain disorders, with a focus on the intracellular, transcellular, and circuit substrates of neural function. For the purposes of this NOFO, the…
Basic mechanisms & biologyTherapeutics & drug discoveryPrevention & risk factorsData & infrastructure
Amount not listedDue Sep 7, 2026≈16% funded · FY24
Closing soonHealthR21Clinical trial: Not allowed
Closes in 29 daysNational Institutes of Health (NIH) · PAR-25-037
This Notice of Funding Opportunity (NOFO) encourages research on the biology of high confidence risk factors associated with complex brain disorders, with a focus on the intracellular, transcellular and circuit substrates of neural function. For the purposes of this NOFO, the…
Basic mechanisms & biologyTherapeutics & drug discoveryPrevention & risk factorsData & infrastructure
Amount not listedDue Sep 7, 2026≈16% funded · FY24
Closing soonHealthClinical trial: Optional / allowed
Closes in 29 daysNational Institutes of Health (NIH) · PAR-23-235
This Funding Opportunity Announcement (FOA) encourages grant applications for Biomedical Technology Resource Centers (BTRCs). BTRCs are national resource centers for conducting research and development on new technologies that are driven by the needs of basic, translational,…
Biomarkers & diagnostics
Amount not listedDue Sep 7, 2026
Closing soonAlzheimer's & dementia (ADRD)R01Clinical trial: Optional / allowed
Closes in 29 daysNational Institutes of Health (NIH) · PAR-25-065
The goal of this Funding Opportunity Announcement (FOA) is to encourage applications for studies that will enhance knowledge of mechanisms associated with neuropsychiatric symptoms (NPS) in persons with Alzheimer's disease (AD) or Alzheimer's disease-related dementias (ADRD).…
Basic mechanisms & biologyTherapeutics & drug discovery
Amount not listedDue Sep 7, 2026≈16% funded · FY24
Closing soonAlzheimer's & dementia (ADRD)R21Clinical trial: Optional / allowed
Closes in 29 daysNational Institutes of Health (NIH) · PAR-25-064
The goal of this Funding Opportunity Announcement (FOA) is to encourage applications for studies that will enhance knowledge of mechanisms associated with neuropsychiatric symptoms (NPS) in persons with Alzheimer's disease (AD) or Alzheimer's disease-related dementias (ADRD).…
Basic mechanisms & biologyTherapeutics & drug discovery
Amount not listedDue Sep 7, 2026≈16% funded · FY24
Closing soonCancer & oncologyR01Clinical trial: Not allowed
Closes in 29 daysNational Institutes of Health (NIH) · PAR-24-306
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) invites applications for projects to expand, improve, or transform the utility of mammalian cancer and tumor models for translational research. With this NOFO, the NCI intends to encourage…
Up to $499KDue Sep 7, 2026≈16% funded · FY24
Closing soonMental health & psychiatricR01Clinical trial: Optional / allowed
Closes in 29 daysNational Institutes of Health (NIH) · PAR-25-039
Although the majority living with schizophrenia and related disorders are over 35 years old, including those first diagnosed and those aging with the illness, the mechanisms underlying the generation and trajectory of the illness remain poorly understood. The purpose of this…
Basic mechanisms & biologyBiomarkers & diagnosticsTherapeutics & drug discoveryPrevention & risk factors
Amount not listedDue Sep 7, 2026≈16% funded · FY24
Closing soonMental health & psychiatricR21Clinical trial: Optional / allowed
Closes in 29 daysNational Institutes of Health (NIH) · PAR-25-040
Although the majority living with schizophrenia and related disorders are over 35 years old, including those first diagnosed and those aging with the illness, the mechanisms underlying the generation and trajectory of the illness remain poorly understood. The purpose of this…
Basic mechanisms & biologyBiomarkers & diagnosticsTherapeutics & drug discoveryPrevention & risk factors
Amount not listedDue Sep 7, 2026≈16% funded · FY24
Closing soonMental health & psychiatricR01Clinical trial: Optional / allowed
Closes in 29 daysNational Institutes of Health (NIH) · PAR-25-067
This initiative seeks to solicit applications for research projects that address the link between social disconnection including both objective social isolation as well as perceived social isolation (otherwise known as loneliness) and suicide in late-life. Emphasis is placed on…
Basic mechanisms & biologyTherapeutics & drug discovery
Amount not listedDue Sep 7, 2026≈16% funded · FY24
Closing soonMental health & psychiatricR21Clinical trial: Optional / allowed
Closes in 29 daysNational Institutes of Health (NIH) · PAR-25-066
This initiative seeks to solicit applications for research projects that address the link between social disconnection including both objective social isolation as well as perceived social isolation (otherwise known as loneliness) and suicide in late-life. Emphasis is placed on…
Basic mechanisms & biologyTherapeutics & drug discovery
Amount not listedDue Sep 7, 2026≈16% funded · FY24
Closing soonSubstance use & addictionClinical trial: Not allowed
Closes in 29 daysNational Institutes of Health (NIH) · PAR-25-347
The goal of this NOFO is to support doctoral candidates from a variety of academic disciplines for up to two years for the completion of the doctoral dissertation research project. Research projects should align with NIDA funding priorities detailed here…
Therapeutics & drug discovery
Amount not listedDue Sep 7, 2026
Closing soonInfectious diseasesClinical trial: Optional / allowed
Closes in 30 daysBill & Melinda Gates Foundation
A family of global-health initiatives that issue periodic open RFPs on high-priority problems (antimicrobial resistance, infectious disease, diagnostics, maternal health), funding investigator-led proposals from seed grants (~$100,000) to large consortia, with no geographic…
Basic mechanisms & biologyBiomarkers & diagnosticsTherapeutics & drug discoveryPrevention & risk factors
Amount not listedDue Sep 8, 2026